Today is 2017-08-23

Trial search
Filter Options
Public title Scientific title Subject ID
Registration Status Registration number Secondary ID
       More Options

11 trials have been registered

Historical versions Registration number Public title Type Registration time
Historical Versions ChiCTR-INR-17012015

Evaluation of the efficacy and safety of single-dose PEG-rhG-CSF, cytarabine and aclaramycin regimens for relapse or refractory acute myeloid leukemia

Xinqiao Hospital, Chongqing

Interventional 2017/05/31
Historical Versions ChiCTR-OPC-16010166

Efficacy and safety of cladribine in combination with G-CSF, low-dose cytarabine and aclarubicin in patients with refractory/relapsed acute myeloid leukemia: a phase 2, single center, single arm study

Sun Yat-sen University Cancer Center

Observational 2016/12/15
Historical Versions ChiCTR-OIC-15007583

Efficacy and safety of cladribine in combination with G-CSF, low-dose cytarabine and aclarubicin in newly diagnosed elderly patients with acute myeloid leukemia: a phase 2, single center, single arm study

Sun Yat-sen University Cancer Center

Observational 2015/12/16
Historical Versions ChiCTR-ONC-11001700

The study of decitabine combination with aclarubicin and cytarabine and granulocyte colony-stimulating factor on the outcome of elderly patients with acute myeloid leukaemia

The First Affiliated Hospital of Nanjing Medical Hospital, Jiangsu Province Hospital

Observational 2011/09/28
Historical Versions ChiCTR-OPN-15006417

High dose Methotrexate (MTX) followed by Etoposide, Cytarabine (EA), stem cell support and temozolomide maintenance therapy in patients with newly diagnosed Primary Central Nervous System B-cell Lymphoma

Department of Hematology, Peking Union Medical College Hospital

Observational 2015/05/13
Historical Versions ChiCTR-IPC-15006301

Cytarabine subcutaneous versus continuous infusion in the treatment of newly diagnosed acute myeloid leukemia patients

The First Affiliated Hospital, Zhejiang University

Interventional 2015/03/17
Historical Versions ChiCTR-OPC-14005712

Cladribine, homoharringtonine and cytarabine (CHA) regimen in the treatment of refractory/relapsed acute myeloid leukemia

Rui Jin hospital affiliated to Shanghai Jiaotong University School of Medicine, Shanghai Institute of Hematology

Observational 2014/12/13
Historical Versions ChiCTR-TRC-13003443

An open-label, single-center, prospective investigation on the efficacy and safety of the chemotherapeutic regimens containing intermediate dosages of cytarabine as consolidation therapy for acute myelogenous leukemia patients

Department of Hematology, the Second Affiliated Hospital of Dalian Medical University.

Interventional 2013/07/21
Historical Versions ChiCTR-ONC-12002055

Gemcitabine, Cisplatin, Dexamethasone, Pegaspargase and Methotrexate (GDPML) followed by Methotrexate, Cytarabine (MA) In Patients with Newly Diagnosed Aggressive T Cell Lymphoma

Hematology Department of Peking Union Medical College Hospital

Observational 2012/03/30
Historical Versions ChiCTR-TRC-08000102

A perspective multi-centre trial of reduced-intensity allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia using fludarabine, busulphan, and cytarabine (FBA) conditioning

Changhai Hospital

Interventional 2008/05/31
First 1 2 Next Last